Moderna has reported top-line data suggesting that its COVID-19 booster vaccine candidate stimulates a strong immune response against The post Moderna...
Paxlovid is the leading oral medication for preventing severe cases of COVID-19 in high-risk individuals. However, symptoms returned in some patients after...
Patients with weakened immune system are at risk for chronic infection and develop highly mutated virus variants Credit: Tel Aviv University Patients with...
June is Myasthenia Gravis Awareness month. As with so many rare diseases, the standard of care for myasthenia gravis (MG) doesn’t address the root of...
People infected with the earliest version of the Omicron variant of the coronavirus, first identified in South Africa in November, may be vulnerable to...
The FDA’s authorization of COVID-19 shots for children ages 6 months to 4 years will bring relief for millions of parents. Pending CDC endorsement, shots...
Although the different SARS-CoV-2 variants currently in circulation are undoubtedly less severe in vaccinated individuals in the general population, immunocompromised...
Researchers at University of California San Diego School of Medicine, Scripps Institution of Oceanography and Rady Children’s Hospital-San Diego teamed...
Over-the-counter COVID tests can quickly show whether you are infected with SARS-CoV-2. But if you have a positive result, there’s no equivalent at-home...
In response to the global COVID-19 pandemic, vaccine research and manufacturing processes have seen unprecedented advancements over a short timeframe....
Biden Administration Sued Over Records On Withholding COVID-19 Treatment From Florida Authored by Zachary Stieber via The Epoch Times (emphasis...
Two broadly neutralizing antibodies show great promise to provide long-acting immunity against COVID-19 in immunocompromised populations according to a...
There has been a growing body of work investigating the role of innate lymphoid cells (ILCs) in immunity and host defense. The more we learn about...
The COVID-19 pandemic has driven RNA into the public eye and there is increasing recognition of its importance in medicine. The intense scientific drive...
Although a handful of companies have dominated the COVID-19 vaccine market in the U.S. and Europe — Pfizer-BioNTech, Moderna, Johnson & Johnson,...
‘Hybrid immunity’ is the term for immunity acquired from both prior infection and vaccination.
Nascent Biotech Inc (OTCMKTS: NBIO) is making a steady run northbound off its base at a nickel and saw some of its biggest gains while the...
GSK will start preparations for regulatory filings of its respiratory syncytial virus (RSV) vaccine straight away, after the The post Relief for GSK as...
Sadly, the COVID-19 pandemic is still with us, despite the accessibility of effective vaccines and treatments. Here’s a look at some of the latest COVID-19...
To help people make informed decisions about ongoing COVID-19 risks, public health messaging needs to adapt as the pandemic evolves, just as immune systems...
Scientists discovered years ago that newborn infants depend upon immune components transferred from their mothers to survive the onslaught of pathogens...
AstraZeneca announced Wednesday that the results of the company's TACKLE Phase III trial of Evusheld (tixagevimab and cilgavimab, formerly AZD7442) for...
Moderna Inc. said on Wednesday a new version of its coronavirus vaccine produced a better immune response against Omicron than the original shot, as the...
Moderna Inc. said on Wednesday an upgraded version of its coronavirus vaccine produced a better immune response as a booster dose against the Omicron variant...
Convergent evolution of three spike protein mutations enhances viral fitness by balancing both positive and negative selection and improves the chances...
The BA.4 and BA.5 sub-variants of Omicron are estimated to make up nearly 5% and 8% of the coronavirus variants in the United States as of...
Pfizer Inc. (NYSE: PFE) is continuing to make efforts toward protecting young children from COVID-19 infection. The company has recently announced that...
Researchers push the boundaries of mRNA technology, creating market opportunities across a range of therapeutic modalities. Progress in each of these modalities...
LA JOLLA, CA—Scientists at La Jolla Institute for Immunology (LJI) have published the first analysis of how four types of COVID-19 vaccines prepare the...
Use of Pfizer Inc.'s COVID-19 antiviral Paxlovid spiked this week, but some doctors are reconsidering the pills for lower-risk patients after a U.S. public...